Weekly Psychedelic Links - September 2022

9.2.22

Cannabis

• Oklahoma Supreme Court Gives Marijuana Activists Temporary Win As They Fight For Legalization Ballot Placement (Marijuana Moment)

• Pharmaceutical Industry Suffers Billions In Losses After States Legalize Marijuana, New Study Finds (Marijuana Moment)

• Harvard Grad Student Dies in Bali From Police Brutality Over Cannabis Arrest (High Times)

• Poll: South Dakota Legalization Initiative in Danger of Failing (High Times)

• More Americans Now Smoke Marijuana Than Cigarettes, For The First Time Ever, Gallup Reports (Marijuana Moment)

• Largest ever independent study into cannabis use (BBC)

• Cannabis researchers say it’s high time to drop ‘lazy stoner’ stereotype (The Guardian)

• Pennsylvania: Governor Launches Effort to Issue Mass Pardons to Those with Low-Level Marijuana Convictions (NORML)

• Ghana's Legal Cannabis Hits a Constitutional Roadblock (TalkingDrugs)

• Joseph Schooling: Singapore Olympic star suspended for taking cannabis in Vietnam (BBC)

• Cannabis industry inches toward sustainability (Chemical and Engineering News)

• New Study Shows Evidence That Low-Dose THC Could Help Treat Veteran PTSD (High Times)

• U.S. Air Force And Space Force Reviewing ‘Common Sense’ Marijuana Drug Testing Policy Change For Recruits (Marijuana Moment)

• Qualitative Study Reveals Medical Students’ Attitudes Toward Medical Pot (High Times)

LSD

• LSD decreases binge-like drinking in a rodent model of alcoholism, but only temporarily (PsyPost)

• Is the Color of LSD an Indicator of Purity? (Lucid News)

MDMA

• Boy, 16, dies in suspected ecstasy-related incident at Leeds Festival (The Independent)

Novel Psychoactive Substances

• DEA Backs Off, Won’t Criminalize Two New Psychedelics (Psychedelic Spotlight)

Nitrous Oxide

• Why Some New York Stores Will Require You to Show ID to Buy Whipped Cream (Newsweek)

• Doctors warn of rise in nerve damage linked to nitrous oxide (The Guardian)

Ketamine

• This New, Legal Cannabis and Ketamine Therapy is Designed to Heal Trauma in the Body (DoubleBlind)

• They’re Pushing Cut-Rate Ketamine Therapy on TikTok (Rolling Stone)

• Yukon woman paid $7K for private ketamine treatment, only to learn that the Yukon gov't covers it (CBC)

Miscellaneous

• An Inside Look at the Lawsuit that could “Legalize Psychedelics in Canada” (Psychedelic Spotlight)

• MindMed Completes 1-for-15 Reverse Share Split (Psychedelic Alpha)

• Student Loan Forgiveness Limited By the War on Drugs (High Times)

• Aspen, Colorado Activists Pursue Psychedelics Decriminalization For 2023 Ballot As Voters Prepare To Decide On Statewide 2022 Legalization Measure (Marijuana Moment)

• Psychedelic Advocate Facing Charges Calls for Help, Law Reform in New York (High Times)

• Is the Psychedelic Therapy Bubble About to Burst? (WIRED)

• In the Wake of Decrim, Police Continue to Target Psychedelics (Lucid News)

• How Psychedelics Might Fuel a Paradigm Shift (DoubleBlind)

9.9.22

Cannabis

• California: Governor Signs Bill Prohibiting Doctors from Discriminating Against Medical Cannabis Patients (NORML)

• Nobody knows how widespread illegal cannabis grows are in California. So we mapped them (Los Angeles Times)

• UK Government Blocks Bermuda From Legalizing Marijuana On Same Day New Prime Minister Takes Office (Marijuana Moment)

• Afroman’s Ohio Residence Raided by Local Law Enforcement (High Times)

• Minnesota Arrests Black People For Marijuana At Much Higher Rates Than White People, State Data Shows (Marijuana Moment)

• New Poll Shows Overwhelming Support for Cannabis Banking Legislation (High Times)

• Companies Turn to THC Beverages as Next Growing Legal Cannabis Market (High Times)

LSD

• LSD-assisted therapy induces rapid and lasting reductions in anxiety and depression symptoms, according to new research (PsyPost)

Magic Mushrooms

• Placebo-controlled study suggests that the benefits of psilocybin microdosing can be explained by expectancy effects (PsyPost)

• Psilocybin Study To Investigate the Serotonin System in Autism (Technology Networks)

• Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History (Psychedelic Alpha)

• 'Flesh of the Gods': The Trippy History of Magic Mushrooms (VICE)

MDMA

• MDMA Enhances Fear Extinction Learning: From Models to Mechanisms (Psychedelic Science Review)

• Police issue MDMA warning after man dies from suspected drug overdose (Radio New Zealand)

Ayahuasca

• Why Are Scientists Dosing Fish with Ayahuasca? (DoubleBlind)

5-MeO-DMT

• As Use Of The World’s Most Potent Psychedelic Skyrockets, New Site F.I.V.E. Fills An Education Void (Forbes)

Peyote

• Conspiracy and Antisemitism in the Debate Over Peyote Decriminalization (Psychedelic Spotlight)

Novel Psychoactive Substances

• New Psychedelic Entactogens: Designer Drugs Produce Designer Effects (Psychedelic Science Review)

Nitrous Oxide

• Laughing gas: 'A 20-second high is not worth losing your life over' (BBC)

Ketamine

• Scientists Discover That a Surprising Factor Improved The Effects of Ketamine in Mice (ScienceAlert)

• Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests (News-Medical.net)

Miscellaneous

• San Francisco decriminalizes psychedelics (Leafly)

• Drug Executions in Iran Are Back on the Rise (TalkingDrugs)

• This Psychedelic Company is Leading the Way on Reciprocity and Holistic Approaches to Healing (DoubleBlind)

• WOC-led psychedelics conference champions gender equality with all-women speakers (Leafly)

9.16.22

Cannabis

• Killings, robberies, extortion. California can’t stop its booming illegal cannabis stores (Los Angeles Times)

• New Zealand Approves Domestic Medical Cannabis Products (High Times)

• World Anti-Doping Agency Set To Keep Marijuana On Banned Substance List, Saying U.S. Didn’t Back Its Removal (Marijuana Moment)

• Biden To Meet With Family of Brittney Griner (High Times)

• Study: CBD Oil Safe, Effective for Autism Patients (High Times)

• Missouri judge blocks attempt to kick legalization off ballot (Leafly)

• GOP Missouri Lawmaker Files Revised Marijuana Legalization Bill, Urging Special Session Action To Compete With Ballot Initiative (Marijuana Moment)

• Pregnant Women in Alabama Are Being Jailed For Smoking Pot (High Times)

• Oklahoma Prosecutors Are Targeting Pregnant Women For Using Medical Marijuana (Marijuana Moment)

• Thai Lawmakers Withdraw Bill to Regulate Cannabis (High Times)

• New Jersey Employers Can’t Punish Workers Based On A Marijuana Test Alone, State Officials Say (Marijuana Moment)

• Nevada Judge Orders State Board to Remove Cannabis from Schedule 1 (High Times)

• Analysis: Legal Cannabis Businesses Associated with Increased Home Values (NORML)

• Weed Legalization in Germany Hampered by EU Laws (High Times)

• What’s Next For Cannabis Mergers And Acquisitions? (Forbes)

• Oregon Officials to Deploy Decoys to Catch Underage Weed, Alcohol Sales (High Times)

• Small Marijuana Growers Could Sell Directly To Consumers Across State Lines Under New Congressional Bill (Marijuana Moment)

• Republican Congressmen Push for Environmental Impact Study on Cannabis (High Times)

• US Court of Appeals: Federal Scheduling of Cannabis “Irrational,” But Not Unconstitutional (NORML)

• In Hawaii, People Prefer Black Market Cannabis to State-Managed Facilities (High Times)

Magic Mushrooms

• Scientists have started to examine whether “magic” mushrooms can help in the fight against obesity (PsyPost)

• Oregon Overcomes Bureaucratic Delays to Therapist Training Program Approvals (Lucid News)

• The shroom edibles market proliferates underground (Leafly)

• Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine Use Disorder and Oral Psilocybin Thin Film Strip Program (Psychedelic Alpha)

DMT

• Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study (Psychedelic Alpha)

Ayahuasca

• Comedian Ron White Shares How Tripping On Ayahuasca In Costa Rica Turned His Life Around (BroBible)

5-MeO-DMT

• ‘I’m not a shaman – I just want to help people’: shoe designer Patrick Cox on his psychedelic toad awakening (The Guardian)

Peyote

• Native American Church of North America Advocates at Capitol Hill for Protections of Peyote (Native News Online)

Synthetic Cannabinoids

• Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014 (Psychedelic Alpha)

Ketamine

• New study highlights ketamine’s promise for treatment-resistant depression (Popular Science)

• Dealers Are Giving Discounts on Cocaine and Ketamine in Honour of the Queen (VICE)

• Study Explores Effects of Experimenter Sex on Ketamine Response (Psychiatric Times)

PCP

• PCP (aka Angel Dust) May Actually Have Therapeutic Potential (DoubleBlind)

Datura

• Datura and the psychedelic Tao (Isham Cook)

Miscellaneous

• Atlanta is considering the decriminalization of magic mushrooms and other psychedelics (Leafly)

• Sexual Abuse in Psychedelic Therapy: Important Steps Being Taken to Support Survivors (DoubleBlind)

• Oregon Voters Continue To Support Drug Decriminalization Law They Approved In 2020, New Poll Shows (Marijuana Moment)

• Psychedelics Were the Hot Topic at This Year’s World Economic Forum (Lucid News)

• Local Michigan Lawmakers Vote To Make September Psychedelics Awareness Month After Decriminalization Enacted (Marijuana Moment)

• A Channel for Magic: Ralph Hood’s Mysticism Scale and the Occult Roots of the Johns Hopkins Psychedelic Research Program (Psymposia)

• Psychedelic Twitter is Swarmed by Plug Bots (Psychedelic Spotlight)

• Finding Nuance in the Psychedelic Hype Bubble (Psychedelic Spotlight)

• Psilera Receives First Patent Allowance for Transdermal Patch Formulations (Psychedelic Alpha)

• Adverse Events in Psychedelic Clinical Trials are Underreported (Psychedelic Spotlight)

• Psychedelic South: The Quest to find Good Drugs in Alabama (Psychedelic Spotlight)

9.23.22

Cannabis

• Canada to review impact of cannabis legalization four years on (Reuters)

• Marijuana Is Staying On The Banned Substances List For International Athletes, World Anti-Doping Agency Announces (Marijuana Moment)

• California: Governor Signs Legislation Providing Employment Protections for Cannabis Consumers (NORML)

• NY finally approves medical homegrow (Leafly)

• Australian Cannabis Patients Turning to Prescriptions Over Illicit Market, Study Shows (High Times)

• New Yorkers with weed convictions will have priority in retail market, state says (Leafly)

• German Lawmakers Tour California Marijuana Businesses To Inform National Legalization Plans (Marijuana Moment)

• Las Vegas City Council Approves Cannabis Consumption Lounges (High Times)

• Leafly Report: ‘Opt-out’ towns are encouraging illegal marijuana sales (Leafly)

• University of Kentucky Opens New Cannabis Research Center (High Times)

• We spoke to the author of that new study on prenatal cannabis exposure (Leafly)

• Apple Lets Users Search For Marijuana And Pharmaceutical Interactions In Latest iPhone Health Update (Marijuana Moment)

• The Role of Cannabis in Treating Long COVID (High Times)

• Canada’s rich and complicated history of psychedelic research (Leafly)

• Oklahoma: Court Rules that Voters Can’t Decide on Legalization Ballot Measure This Year (NORML)

• Arkansas: High Court Approves Marijuana Legalization Measure for the November Ballot (NORML)

• Majority Of Maryland Voters Back Marijuana Legalization Referendum And Expungements, Poll Finds (Marijuana Moment)

• Two Out Of Three Missouri Voters ‘Certain To Vote Yes’ On Marijuana Legalization Ballot Initiative, Poll Finds (Marijuana Moment)

• Poll: Majority in Minnesota Want Legal Weed (High Times)

• Two In Three Pennsylvania Voters Support Marijuana Legalization, New Poll Shows Amid Key Political Races (Marijuana Moment)

LSD

• Miami clinic kicks off first national study of LSD, once a ‘public enemy,’ to treat anxiety (Miami Herald)

Magic Mushrooms

• The Viagra of the Himalayas—the World’s Most Expensive Fungus—Faces Serious Decline Due to Growing Demand (DoubleBlind)

• Liquid Culture vs. Spores (Reality Sandwich)

MDMA

• Disruption to Australian ecstasy market following COVID-19 restrictions, report finds (Medical Xpress)

• MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances (Psychedelic Alpha)

DMT

• Researchers Studying Psychedelic Drug as Treatment for Alzheimer’s Disease (High Times)

Ayahuasca

• Packers Bust Out Ayahuasca TD Celebration Weeks After Aaron Rodgers Revealed Psychedelic Use (BroBible)

• Aaron Rodgers Defends Ayahuasca, Says He May Be 'Called' to Take the Psychedelic Again (People)

Peyote

• Native American Church Leaders Ask Congress For Funds To Support Peyote Cultivation And Preservation (Marijuana Moment)

• The Complicated Ethics of Legalizing Indigenous Psychedelic Substances (Ethos)

Iboga

• You Can Now Get Ibogaine-Based Addiction Treatment In A Hospital Setting In Brazil (Forbes)

Nitrous Oxide

• What Nitrous Oxide Showed The Father of American Psychology (Lucid News)

Ketamine

• Looking at Images of People Smiling at You Extends Antidepressant Effects of Ketamine (Neuroscience News)

DXM

• Please don't cook chicken in NyQuil, the FDA asks TikTok users (NPR)

• The FDA may have unintentionally made 'NyQuil Chicken' go viral on TikTok (Engadget)

Miscellaneous

• Math Over Myth: Psychedelic Stock HAVN Life Collapses (Psychedelic Spotlight)

• Psychedelics face corrupting influence of financial interests (UC News)

• Biden Administration Considers Psychedelic Therapies Task Force (Lucid News)

• Colorado Polls Show Conflicting Results On Psychedelics Ballot Measure That Voters Will Decide On In November (Marijuana Moment)

• Algernon Pharmaceuticals Announces Receipt of CDN $450K Cash Refund from Australian Research Program (Psychedelic Alpha)

• Baby Boomers (Re)Discover Psychedelics as Tools for Aging with Grace (DoubleBlind)

• Does Microdosing Impact Meditation? New Study From Beckley Foundation and Quantified Citizen Investigates (Newswire)

• Colombia’s President Tells UN That ‘Democracy Will Die’ If World Leaders Don’t End Drug War And Pursue Different Strategy (Marijuana Moment)

• The Undergrowth of Psychedelic Australia (Kahpi)

• Beyond Michael Pollan: Where to learn more about psychedelics. (Medium)

• Can Psychedelics Help Veterans with Chronic Pain? (Psychedelic Spotlight)

9.30.22

Cannabis

• Switzerland: Revision of Narcotics Act – Switzerland fully legalizes medicinal cannabis (Global Compliance News)

• Free medicinal cannabis to be donated to epileptic children in the UK (Sky News)

• Medical cannabis for doggies, kitties is fully legalized in California (Leafly)

• Medical Marijuana Helps Patients Reduce Use Of Addictive Opioid Painkillers, Study Finds (Marijuana Moment)

• Maltese Non-profit Cannabis May be The Way Forward (TalkingDrugs)

• Check in, smoke up and tune out: Cannabis-friendly vacation rentals are catching on (CNBC)

• Despite The Munchies, Marijuana Legalization Is Tied To Lower Obesity Rates, Stereotype-Busting Study Finds (Marijuana Moment)

• Investigators say more than 70% of cannabis growers use illegal water (Santa Barbara News-Press)

• Germany Versus The United States: Which Will Legalize Cannabis First (Forbes)

• As cannabis usage grows, so does the need for employers to revisit their workplace drug policies (The Philadelphia Inquirer)

• Could Cannabis and Psychedelic Drugs Make Breast Cancer Treatments More Effective? (PR Newswire)

• Federal Marijuana Prohibition Is Putting Patients At Risk Of Consuming Contaminated Products, Study Finds (Marijuana Moment)

• Supreme Court trial on homegrow ban reveals a bigger issue in federal cannabis legalization (Leafly)

• Medical Marijuana Patient Plans To Sue Feds For $3.5 Million Over ‘Discriminatory’ Cannabis Raid On Tribal Land (Marijuana Moment)

• Is Big Tobacco Pivoting to Big Cannabis? (High Times)

• Wisconsin Governor’s Push To Allow Ballot Initiatives Could Put Marijuana Legalization Before Voters (Marijuana Moment)

• Majority Of D.C. Voters Support Marijuana Legalization And Oppose Crackdown On Unregulated ‘Gifting’ Market, Poll Finds (Marijuana Moment)

• Missouri Marijuana Legalization Ballot Initiative Leads In New Poll, But With Less Than 50 Percent (Marijuana Moment)

LSD

• Effects of LSD and Psilocybin in Healthy Participants (Psychiatric Times)

Magic Mushrooms

• Connecticut to Offer Legal MDMA and Psilocybin Therapy as Early as Next Year (DoubleBlind)

• DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests (Benzinga)

• Woman’s Breast Cancer Returned Immediately After Dropping Treatment With Cannabis, Shrooms (High Times)

• Psilocybin Shows Gender-Specific Effects on CNS Reactivity and Behavioral Responses (Gilmore Health News)

• Psyence Group Completes Export of Psilocybin Mushrooms to Portugal (Psychedelic Alpha)

MDMA

• MDMA in the UK Is Finally Pure Again (VICE)

Ayahuasca

• Aaron Rodgers fumbles the science on psychedelics. Drugs like ayahuasca can alter the brain—but how? (Salon)

Novel Psychoactive Substances

• 'A lot of MDMA that wasn't MDMA': The early results from inside Australia's first drug testing clinic (SBS)

• atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01 (Psychedelic Alpha)

• LSD-Like Molecules Counter Depression Without the Trip (UC San Francisco)

• BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives (Psychedelic Alpha)

Synthetic Cannabinoids

• A new urine test could help curtail the use of the latest synthetic cannabinoids to enter the drug scene (Medical Xpress)

Ketamine

• Elijah McClain’s autopsy report changed to death by ketamine (Colorado Public Radio)

• Looking at smiling faces extends the antidepressant effects of ketamine (University of Pittsburgh)

Miscellaneous

• How Interdisciplinary Research Could Reveal Psychedelics’ Blind Spots (Microdose)

• New Theory Believes Psychedelics Could Benefit Long-Term Space Travelers (High Times)

• After rocky start, hopes up in Oregon drug decriminalization (ABC)

• Psychedelic drugs: how to tell good research from bad (The Conversation)

• Do You Even Trip, Bro? A Look At Psychedelic Masculinity, From Joe Rogan To Mike Tyson (Benzinga)

• I went to the only psychedelic dispensary in North America—here’s how they do it (The Manual)

• The Racism and Classism Hidden Behind “Moms who Microdose” (Psychedelic Spotlight)

• Whole-Body Effects of Psychedelics Part 3 – The Heart (Psychedelic Science Review)

• Majority Of Mainers Support Drug Decriminalization And Other Harm Reduction Policies, Poll Finds (Marijuana Moment)

• Why Tripping at Raves Can Be Just As Healing as Ceremony (DoubleBlind)

• Math Over Myth: MindMed’s Self Destructive Stock Mission (Psychedelic Spotlight)

• Men More Likely To Have Substance Abuse Disorder, Women More Likely To Overdose (High Times)

• Psychedelic Retreats Offer Healing Only for the Wealthy (Psychedelic Spotlight)

• Psychedelic therapy could reduce anxiety, distress among patients with cancer (Healio)

• The Narrowing of Psychedelic Discourse (Psychedelic Spotlight)

• Is Now a Good Time to Invest In Psychedelics Stocks? (The Motley Fool)

• The Messy Job of a Psychedelic Integration Coach (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.24.21

Cannabis

• Analysis: Unregulated Delta-8 Vape Products Frequently Mislabeled, May Contain Heavy Metals (NORML)

• Malta Officially Legalizes Marijuana With President’s Signature, Becoming First In Europe To End Cannabis Prohibition (Marijuana Moment)

• Several States to Usher In the New Year with Cannabis Liberalization Laws (NORML)

• The Next States to Legalize Recreational Marijuana (MSN)

• Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition (Forbes)

• Scientists are (finally) studying how weed affects athletic performance and recovery (Leafly)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Gay, Lesbian And Bisexual People (Marijuana Moment)

• Cartels Ditch Pot and Opium Fields for Synthetic Drugs, Mexico Defense Secretary Says (High Times)

• Ohio: Citizens’ Petition Seeks to Compel Lawmakers to Hold Marijuana Legalization Vote (NORML)

• Senator Calls For Federal Marijuana Standard To Measure Impaired Driving (Marijuana Moment)

• Top Maryland Lawmaker Files Marijuana Legalization Referendum For 2022 Ballot (Marijuana Moment)

• Iowa Democrats Announce Plan To Let Voters Decide On Marijuana Legalization Amid GOP Resistance (Marijuana Moment)

• Whole-Plant Cannabis Extract Reduces Epileptic Seizures By 86% in Small Study (High Times)

• Researcher Uses Reddit To Learn What Kinds Of Marijuana Posts Influenced Legalization Attitudes (Marijuana Moment)

• Pair of Cops Booked After Being Caught Smoking Pot in Mississippi (High Times)

• Marijuana Group Releases ‘Robbery Preparedness Guide’ For Dispensaries Amid Spike In Thefts (Marijuana Moment)

• Dr. Sanjay Gupta adds to chorus of cannabis research on autism in 2021 (Leafly)

• Legal Cannabis Outsells Ontario Illicit Market for First Time (High Times)

• These were the weirdest weed news stories of 2021 (Leafly)

LSD

• U.S. FDA puts plans to test LSD in anxiety patients in clinical study on hold (Reuters)

Magic Mushrooms

• Canada’s Psilocybin Policy Reform Movement Continues to Make Progress Federally (Truffle Report)

• FDA Approves Psilocybin For Binge Eating Study By Tryp Therapeutics (Benzinga)

Ayahuasca

• Global ayahuasca trend drives deforestation in Brazil’s Acre state (Mongabay)

Morning Glory Seeds

• Study shows common flower species holds promise for beneficial psychedelic drugs (Newswise)

Ketamine

• Ketamine Therapy Quickly Reduces Depression and Suicidal Thoughts (SciTechDaily)

DXM

• Cough medicine creates dangerous interaction (The Seattle Times)

Miscellaneous

• Port Townsend Becomes 13th City to Decriminalize Psychedelics (DoubleBlind)

• Psychedelics: The newest tool in nuclear negotiations? (Bulletin of the Atomic Scientists)

• How Should Psychedelic Medicine Handle “Flashbacks”? (Mad in America)

• New center to study psychedelics pops up at University of Texas at Austin (My San Antonio)

• The Dumbest Drug Scare Stories of 2021 (VICE)

• DEA Wants To Help Parents Decode The Emojis Young People Use To Discuss Marijuana And Other ‘Bomb Ass’ Drugs (Marijuana Moment)

• GOP Lawmakers File Bills To Streamline Research Into Marijuana, Psychedelics And Other Schedule I Drugs (Marijuana Moment)

• Colorado Ballot Initiatives Filed to Legalize Psychedelics (Truffle Report)

• Two Leaders in Psychedelics Industry and the Harm Reduction Approach (Nasdaq)

• How Do Hallucinogenic Drugs Change Our Personality? (Psychology Today)

• Microdosing companion app Houston wants to be your guide to 'inner space' (Mashable)

• Why Psychedelic Research May Bring the Next Big Breakthrough in Dementia Treatment (Psychedelic Spotlight)

• MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.29.21

Cannabis

• With export restrictions eased, Colombia's medical cannabis business is poised for liftoff (CNN)

• Federal Survey Identifies Marked Decline in Youth Marijuana Use (NORML)

• Why did Texas ban Delta-8? (Popular Science)

• Cannabis products may help treat symptoms of depression, improve sleep, and increase quality of life, study suggests (PsyPost)

• California Destroys 1M Plants in Marijuana Eradication Campaign (High Times)

• State Attorneys General Warn About Marijuana-Infused Candy And Snacks Ahead Of Halloween (Marijuana Moment)

• The Myth of Cannabis-Infused Halloween Candy—Debunked (High Times)

• Cannabis is one industry that's actually coming out of Covid even stronger (CNN)

• South Dakota Lawmakers Approve Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

• New York: Officials Moving to Clear Over 400,000 Past Marijuana Convictions (NORML)

• Montana Supreme Court Unanimously Overturns a Pot Conviction, Saying Cops Stopped the Defendant for No Good Reason (Reason)

• Analysis: ‘Government-Grade’ Marijuana More Closely Resembles Hemp, Has Little in Common with Commercially Available Cannabis (NORML)

• Florida judge rules online marijuana ordering sites may resume business (Marijuana Business Daily)

• Louisiana plans to regulate, not ban, delta-8 THC (Marijuana Business Daily)

• Former Arkansas Lawmaker Launches Campaign To Put Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Maryland: Most Residents Want to Legalize Marijuana for Adult Use (NORML)

LSD

• Ex-Denver Cop Who Broke Teen's Face for Dancing on LSD to Cost City $1.2 Million (Westword)

Magic Mushrooms

• Study Finds Psilocybin Improves MDD in Patients With Cancer (Psychiatric Times)

• Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property (STAT)

• Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum (Marijuana Moment)

• Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut (High Times)

• More Evidence of the Chemical Compound Variability in Magic Mushrooms (Psychedelic Science Review)

• MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

• Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome (PR Newswire)

MDMA

• No One Is Wasting Their Ecstasy on Your Kids' Halloween Candy (Reason)

• MindMed Announces R(-)-MDMA Program to target Social Anxiety Associated with Autism Spectrum Disorder (Psilocybin Alpha)

Ayahuasca

• Des Moines church fights IRS over ‘religious’ use of hallucinogenic drug (Iowa Capital Dispatch)

5-MeO-DMT

• Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT (Psilocybin Alpha)

Novel Psychoactive Substances

• Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin (Psilocybin Alpha)

• Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease (Psilocybin Alpha)

• Awakn Life Sciences Identifies New Chemical Series Via Its Drug Discovery Program (Awakn Life Sciences)

• Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds (Yahoo! Finance)

Synthetic Cannabinoids

• The Dangers of 'Spice' and Other Synthetic Cannabinoids (Discover Magazine)

Ketamine

• European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders (Psilocybin Alpha)

• Cocaine, ketamine use on the rise: survey (PerthNow)

• Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology (Psilocybin Alpha)

• MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform (Psilocybin Alpha)

Miscellaneous

• Canadian entrepreneur gifts $5 million to help create psychedelic research centre for mental health (CTV News)

• Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (GQ)

• Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC (Marijuana Moment)

• Addressing Abuse in Psychedelic Spaces (Psychedelics Today)

• North America Continues Leading The Way In Psychedelic Wellness (PR Newswire)

• Psychedelic Patents Should Be Limited, Harvard Law Experts Say (Psychedelic Spotlight)

• Could Psychedelics Cure Our Post-Pandemic Depression? (Truffle Report)

• How Gender Affects the Way We Use Drugs (TalkingDrugs)

• DC Voters Strongly Support Drug Decriminalization, Poll Finds As Activists Launch Campaign (Marijuana Moment)

• MAPS Canada’s Data Breach Foreshadows Corporadelic Future (Psymposia)

• Wavepaths: The Neuroscientist-Founded Company Producing Music For—And As—Psychedelic Therapy (Forbes)

• Novamind Brings Contract Research To Psychedelic Medicine (Lucid News)

• Psychedelic Research Beyond Depression & Trauma (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.2.21

Cannabis

• Mexico’s Supreme Court Strikes Down Marijuana Prohibition After Lawmakers Fail To Act (Marijuana Moment)

• New Mexico Marijuana Legalization Law Officially Takes Effect (Marijuana Moment)

• Clarence Thomas says federal laws against marijuana may no longer be necessary (NBC News)

• The UN Is Trying Really Hard to Pass a Global Ban on Weed Advertisements (MERRY JANE)

• NC Senate panel approves medical marijuana bill (WRAL)

• Sha'Carri Richardson, U.S. sprinter, out of 100m event at Tokyo Olympics after failing drug test (CBS Sports)

• Pennsylvania: Governor Signs Legislation Expanding Medical Cannabis Access for Qualified Patients (NORML)

• Apple Now Allows Marijuana Businesses On Its App Store, While Google Maintains Ban (Marijuana Moment)

• Flint’s old police academy sold for marijuana grow facility despite objections (MLive.com)

• Delaware Marijuana Legalization Effort Dead For This Session, Bill Sponsor Says Following Equity Disagreements (Marijuana Moment)

• The Biden Administration Is Trying to Block Medical Cannabis Research for Veterans (MERRY JANE)

• State lawmakers weigh options as hemp-derived delta-8 THC disrupts marijuana market (Marijuana Business Daily)

• House Approves Bill To Let Researchers Access Marijuana From State-Legal Dispensaries (Marijuana Moment)

• Weed Smokers Are Exposed to Fewer Toxic Chemicals Than Cigarette Smokers, Study Finds (MERRY JANE)

• Massachusetts Cannabis Workers Unionize, Part of a National Movement (Filter)

• Short-Term Cannabis Use Helps Chronic Insomniacs Get Solid Sleep, Study Says (MERRY JANE)

LSD

• Can LSD Treat Food Allergies? We Don’t Know, But It’s Already Been Patented (VICE)

• Mouse Study Uncovers LSD Mechanism That Promotes Positive Social Behavior (StreetInsider.com)

Magic Mushrooms

• Oregon Psilocybin Board On Track To Meet Timeline Goals (Truffle Report)

• Comparing Psilocybin Mushroom Bruising with Trichoderma Infection (Psychedelic Science Review)

• COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression (Psilocybin Alpha)

• DEA Asks Appeals Court to Drop Psilocybin Lawsuit (Truffle Report)

• Psilocybin Dispensaries Could Soon Be Coming: What’s That Mean For Psychedelic Therapy? (Healing Maps)

• Why Has Growing Magic Mushrooms At Home Suddenly Started To Boom? (Healing Maps)

Ayahuasca

• First-Ever Study Looks At Ayahuasca’s Impact On DNA Expression (Forbes)

• Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy (Chacruna)

• Ayahuasca relieves depression and anxiety, finds study on nearly 12,000 users (ZME Science)

• Ayahuasca Research: Where Science Meets Spirituality (The Third Wave)

Mescaline

• Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests (PsyPost)

Iboga

• Traditional Missoko Bwiti Iboga Pre-Initiations offered outside of Gabon (EIN News)

Ketamine

• Ketamine And Seizures: Can One Lead To The Other? (Healing Maps)

• IV Ketamine Shown to Be Effective and Safe for Cancer-Related Neuropathic Pain (Clinical Pain Advisor)

Miscellaneous

• California Lawmakers Approve Bill To Legalize Psychedelics Possession In Committee (Marijuana Moment)

• Helping Drug Users Survive, Not Abstain: ‘Harm Reduction’ Gains Federal Support (The New York Times)

• Harvard University Launches First-Of-Its-Kind Psychedelics Policy Center (Marijuana Moment)

• UN Highlights Role of Drug War in Racist Policing (TalkingDrugs)

• Maine Senate Defeats Drug Decriminalization Bill That Cleared The House (Marijuana Moment)

• Why a UNC professor is on a quest to remove the ‘trip’ from psychedelic drugs (The News & Observer)

• The War on Drugs Comes to the Doctor’s Office (Truthout)

• Early warning system for dangerous drugs reaches online audience of more than a million in a year (Stuff.co.nz)

• How to Survive the Psychedelic Renaissance (Maps of the Mind)

• Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board (Psilocybin Alpha)

• Psychedelics as a Treatment for Alzheimer’s (Reality Sandwich)

• Can Psychedelics Open Us to Pleasure? (Chacruna)

• What Is Transpersonal Psychology and How Does It Relate to Psychedelics? (Psychedelics Today)

• The Medicine Path (Maps of the Mind)

• Research Adds to Weight of Evidence on People Checking Drugs They Sell (Filter)

• Psychedelic Treatment for Eating Disorder Recovery (Psychedelic Science Review)

• Exploring Research on Psychedelics and Autism (Reality Sandwich)

• Microdosing, And The Gentrification Of Psychedelic Culture (Forbes)

• Militarism, Prohibitionism, Drug War: A Formula for Massacre (TalkingDrugs)

• An Insight Into Psychedelic Stocks (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.